Pharmacogenetics or predictive genetics? APOE testing blurs the lines
The integration of pharmacogenetics into personalized medicine enables the optimization of drug selection and dosage, maximizing therapeutic benefits while minimizing the risk of adverse drug reactions. The association between APOE alleles and ARIA, a known adverse reaction in Alzheimer’s disease pa...
Saved in:
| Main Authors: | Stefania Zampatti, Cristina Peconi, Juliette Farro, Fabrizio Piras, Clelia Pellicano, Carlo Caltagirone, Emiliano Giardina |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1627239/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alzheimer's Prevention Initiative Generation Program: Development of an APOE genetic counseling and disclosure process in the context of clinical trials
by: Carolyn M. Langlois, et al.
Published: (2019-01-01) -
APOE2 reduces risk of Alzheimer's disease by protection of lysosomes from lipid overloading
by: Jing Feng, et al.
Published: (2025-08-01) -
From Genomics to AI: Revolutionizing Precision Medicine in Oncology
by: Giulia Calvino, et al.
Published: (2025-06-01) -
Patients with Alzheimer's disease who carry the APOE ε4 allele benefit more from physical exercise
by: Camilla Steen Jensen, et al.
Published: (2019-01-01) -
APOE GENE POLYMORPHISM: THE IMPACT OF APOE4 ALLELE ON SYSTEMIC INFLAMMATION AND ITS ROLE IN THE PATHOGENESIS OF ALZHEIMER’S DISEASE
by: I. K. Malashenkova, et al.
Published: (2018-06-01)